Chemed Inc (CHE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 40,222 | 16,856 | 74,515 | 129,752 | 249,904 |
| Receivables | 188,634 | 215,479 | 182,575 | 215,570 | 184,880 |
| Inventories | 7,630 | 7,208 | 7,543 | 8,238 | 9,148 |
| TOTAL | $291,235 | $274,063 | $302,616 | $395,243 | $491,377 |
| Non-Current Assets | |||||
| PPE Net | 208,499 | 207,734 | 205,662 | 203,939 | 202,281 |
| Investments And Advances | 148,153 | 143,778 | 140,347 | 136,021 | 129,560 |
| Intangibles | 777,999 | 767,918 | 749,763 | 751,917 | 754,356 |
| Other Non-Current Assets | 153,699 | 142,322 | 139,801 | 136,499 | 140,273 |
| TOTAL | $1,288,350 | $1,261,752 | $1,235,573 | $1,228,376 | $1,226,470 |
| Total Assets | $1,579,585 | $1,535,815 | $1,538,189 | $1,623,619 | $1,717,847 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 84,713 | 65,698 | 64,459 | 48,095 | 50,864 |
| Accrued Expenses | 136,249 | 127,851 | 120,383 | 145,401 | 121,576 |
| Other current liabilities | 57,607 | 60,810 | 58,892 | 55,063 | 47,746 |
| TOTAL | $319,846 | $321,415 | $287,130 | $292,041 | $263,886 |
| Non-Current Liabilities | |||||
| Long Term Debt | 140,000 | 91,200 | 0 | N/A | N/A |
| Other Non-Current Liabilities | 127,193 | 117,971 | 116,202 | 112,828 | 115,074 |
| TOTAL | $429,229 | $366,406 | $271,654 | $254,895 | $255,476 |
| Total Liabilities | $749,075 | $687,821 | $558,784 | $546,936 | $519,362 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 13,070 | 13,274 | 13,765 | 14,164 | 14,572 |
| Common Shares | 37,613 | 37,607 | 37,595 | 37,593 | 37,593 |
| Retained earnings | 3,073,331 | 3,013,504 | 2,955,375 | 2,887,123 | 2,831,540 |
| Other shareholders' equity | 2,441 | 2,153 | 2,238 | 1,900 | 2,187 |
| TOTAL | $830,510 | $847,994 | $979,405 | $1,076,683 | $1,198,485 |
| Total Liabilities And Equity | $1,579,585 | $1,535,815 | $1,538,189 | $1,623,619 | $1,717,847 |